Figure 3From: Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient miceA: Number of alveoli per lung. B: Mean alveolar volume. Already after 3 weeks of treatment an increase in alveolar number and a decrease in alveolar volume was observed.Back to article page